SCHEDULE: Janus Henderson Discloses 8.5% Stake in Akero Therapeutics
Beneficial Ownership Report
Janus Henderson Group plc has disclosed an 8.5% beneficial ownership stake in Akero Therapeutics, Inc. as of June 30, 2025.
Summary
- Janus Henderson Group plc, a Jersey-based entity, reported beneficial ownership of 6,738,556 Ordinary Shares of Akero Therapeutics, Inc.
- This ownership represents 8.5% of Akero Therapeutics, Inc.'s class of securities.
- Janus Henderson Group plc holds both shared voting power and shared dispositive power over all 6,738,556 shares.
- The filing is an Amendment No. 10 to a previously filed Schedule 13G.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of Akero Therapeutics, Inc.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a significant institutional investment in a biotechnology company, common within the financial industry for transparency regarding large holdings.
Stakeholder Impact
- Shareholders: Disclosure of a significant institutional holder provides transparency regarding the company's ownership structure and may influence investor perception.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of execution of Power of Attorney by Janus Henderson Group plc. |
| 2025-06-30 | Date of event which required the filing of this statement. |
| 2025-08-14 | Date of filing of this statement. |
Keywords
Akero Therapeutics, Janus Henderson, Beneficial Ownership, Schedule 13G, Investment Adviser, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.